title
Resolution authorizing the Mayor and the Department of Law and/or the Director of the Department of Finance, on behalf of the City of Pittsburgh, in full and final settlement related to the litigation at City of Pittsburgh v. Purdue Pharma, L.P. et al., Case No. 18-006153, as coordinated in In Re Opioid Litigation, No. 2017-00895 (Delaware County, PA) stemming from In Re: National Prescription Opiate Litigation Case No. 1:17-md-2804 in the US District Court for the Northern District of Ohio, MDL 2804 initially as to the Defendants McKesson Corporation, Cardinal Health, Inc. and AmeriSource Bergen Corporation, Johnson and Johnson, Janssen Pharmaceuticals, Inc., Ortho-McNeil-Pharmaceuticals, Inc., and Janssen Pharmaceutica, Inc., and any future settling Defendants, to accept a yearly allocation of funds into a special revenue account to be subsequently created to accept the funds of this settlement as determined by Pennsylvania's Intrastate Opioid Trust & Allocation Order.
(Executive Session held 3/16/22)
body
WHEREAS: The City of Pittsburgh agrees to participate in a statewide settlement agreement resolving claims between Defendants Cardinal, McKesson, and AmerisourceBergen, as pharmaceutical distributors, and Johnson & Johnson, as an opioid manufacturer, and numerous litigating and non-litigating state and local governments in Pennsylvania. This legislation makes the City of Pittsburgh eligible to receive settlement funds pursuant to Pennsylvania's intrastate allocation agreement as further described below and in Pennsylvania Intrastate Allocation Agreement.
WHEREAS: According to Pennsylvania's Attorney General's Office the settlement between the above mentioned parties resulted from investigations by state attorneys general into whether the three distributors fulfilled their legal duty to refuse to ship opioids to pharmacies that submitted suspicious drug orders and whether Johnson & Johnson misled patients and doctors about the addictive nature of o...
Click here for full text